Kelsey Elizabeth Hirotsu, MD
Dermatology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hirotsu’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A156863 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$376,945
Medicare paid this office $376,945 for 498 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 278 | $85,999 | $224 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 170 | $60,200 | $168 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 44 | $36,167 | $786 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 41 | $25,750 | $613 |
| Short return visit (20+ min) | 175 | $16,034 | $58 |
See all 32 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 278 | $85,999 | $224 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 170 | $60,200 | $168 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 44 | $36,167 | $786 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 41 | $25,750 | $613 |
| Short return visit (20+ min) | 175 | $16,034 | $58 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 49 | $13,764 | $241 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 17 | $13,421 | $789 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 17 | $11,615 | $683 |
| Full thickness skin graft to forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 20.0 sq cm or less | 14 | $10,948 | $684 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 65 | $10,304 | $147 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 31 | $8,489 | $157 |
| Return visit (30+ min) | 70 | $7,520 | $95 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 13 | $7,348 | $565 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 11 | $6,740 | $613 |
| New patient visit (45+ min) | 49 | $5,457 | $111 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 55 | $5,369 | $93 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 37 | $3,279 | $75 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | 25 | $3,249 | $125 |
| Destruction of precancer skin growth, 1 growth | 43 | $2,586 | $43 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 26 | $2,487 | $89 |
| Biopsy of related skin growth, first growth | 49 | $2,218 | $33 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | 20 | $1,883 | $90 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 13 | $1,661 | $119 |
| New patient visit (30+ min) | 25 | $1,624 | $65 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 16 | $1,348 | $79 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 14 | $1,346 | $90 |
| Biopsy of related skin growth, each additional growth | 20 | $1,097 | $21 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 11 | $1,003 | $91 |
| Application of chemical to stop tissue regrowth in wound | 16 | $992 | $35 |
| Special stained specimen slides to examine tissue, initial procedure | 19 | $958 | $31 |
| Injection into skin growth, 1-7 growths | 21 | $809 | $25 |
| Destruction of precancer skin growth, 2-14 growths | 23 | $575 | $4 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 117 | More than 94% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of skin cancer | 574 | More than 66% of doctors who do this |
| Removal of skin lesions | 137 | More than 77% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 68 | More than 72% of doctors who do this |
Who their Medicare patients are
498 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 17% · Women 48% · Also on Medicaid 16% · Health risk score 1.41. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 66% · Coronary heart disease 26% · Chronic kidney disease 26% · Atrial fibrillation 23% · Diabetes 20% · Cancer 20% · Heart failure 15% · Depression 12% · COPD 11% · Stroke 9% · Dementia 7%.
The office billed $3,027,568, Medicare allowed $484,760 and paid $376,945; for 2,359 services of 91 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 498 | 2,359 | 76 | 1.41 | $3,027,568 | $376,945 |
| 2023 | 351 | 1,264 | 76 | 1.42 | $1,589,166 | $220,282 |
| 2022 | 262 | 649 | 76 | 1.34 | $722,724 | $114,452 |
| 2021 | 92 | 122 | 76 | 1.52 | $60,185 | $15,322 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 179 | $51,100 | $223 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 95 | $27,069 | $170 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 23 | $18,120 | $788 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 19 | $12,124 | $577 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 34 | $9,667 | $230 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 13 | $8,875 | $683 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 11 | $8,537 | $776 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 52 | $8,240 | $147 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 14 | $7,581 | $505 |
| Short return visit (20+ min) | 62 | $4,321 | $59 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 18 | $4,256 | $158 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 39 | $3,806 | $95 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 17 | $2,834 | $167 |
| New patient visit (45+ min) | 24 | $2,748 | $114 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 32 | $2,558 | $80 |
| Return visit (30+ min) | 24 | $2,289 | $88 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 19 | $2,235 | $118 |
| New patient visit (30+ min) | 30 | $2,110 | $70 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 16 | $1,804 | $100 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | 11 | $1,401 | $127 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 16 | $1,359 | $85 |
| Destruction of precancer skin growth, 1 growth | 26 | $1,320 | $41 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | 12 | $1,238 | $103 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 12 | $1,194 | $100 |
| Biopsy of related skin growth, first growth | 26 | $1,123 | $42 |
| Destruction of skin growth, 1-14 growths | 12 | $1,090 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $449 | $5 |
| Short return visit | 15 | $343 | $23 |
2022: 15 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 75 | $19,829 | $220 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 40 | $9,587 | $168 |
| Return visit (30+ min) | 74 | $6,086 | $79 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 32 | $5,117 | $155 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 17 | $4,330 | $255 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 15 | $4,259 | $224 |
| New patient visit (45+ min) | 18 | $2,033 | $113 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 20 | $1,896 | $95 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 14 | $1,810 | $129 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 14 | $1,537 | $110 |
| Short return visit (20+ min) | 20 | $1,389 | $69 |
| Biopsy of related skin growth, first growth | 21 | $1,279 | $61 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 13 | $1,273 | $98 |
| New patient visit (30+ min) | 14 | $1,225 | $88 |
| Short return visit | 12 | $587 | $39 |
2021: 2 services
| Return visit (30+ min) | 59 | $6,845 | $112 |
| New patient visit (45+ min) | 13 | $1,876 | $144 |
Medicaid work
$10,762 in 2024
Medicaid paid $10,762 for 50 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; each additional stage after the first stage, up to 5 tissue blocks (List separately in addition to code for primary procedure) | 12 | $6,430 |
| Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; first stage, up to 5 tissue blocks | 38 | $4,331 |
| 2024 | 50 | 2 | 14 | $10,762 |
Drugs they prescribed that Part D paid
$42,498
Pharmacies billed $42,498 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (38 of 350) in 2024. A higher opioid share than 9 in 10 peers; the typical dermatology clinician is at 0%.
342 generic and fewer than 11 brand-name prescriptions · $42,498 in drug cost · 204 antibiotic prescriptions to 168 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 169 | $866 | $5 |
| Fluorouracil | 13 | $736 | $57 |
| Triamcinolone Acetonide | 18 | $224 | $12 |
| Doxycycline Monohydrate | 22 | $215 | $10 |
| Acetaminophen-Codeine | 31 | $95 | $3 |
See all 6 drugs
| Cephalexin | 169 | $866 | $5 |
| Fluorouracil | 13 | $736 | $57 |
| Triamcinolone Acetonide | 18 | $224 | $12 |
| Doxycycline Monohydrate | 22 | $215 | $10 |
| Acetaminophen-Codeine | 31 | $95 | $3 |
| Hydrocortisone | 12 | $28 | $2 |
Year by year
| 2024 | 350 | 211 | 11% (38) | None | $42,498 |
| 2023 | 185 | 124 | 16% (29) | 0% | $2,511 |
| 2022 | 268 | 229 | 8% (21) | 0% | $2,996 |
| 2021 | 168 | 129 | None | None | $17,735 |
| 2020 | 135 | 57 | None | None | $17,296 |
| 2019 | 41 | 23 | None | None | $2,464 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Cephalexin | 91 | $778 | $9 |
| Triamcinolone Acetonide | 11 | $122 | $11 |
| Acetaminophen-Codeine | 27 | $90 | $3 |
| Clindamycin | 12 | $77 | $6 |
2022: 3 drugs
| Doxycycline Hyclate | 156 | $1,354 | $9 |
| Cephalexin | 58 | $422 | $7 |
| Acetaminophen-Codeine | 18 | $85 | $5 |
2021: 2 drugs
| Doxycycline Hyclate | 93 | $1,131 | $12 |
| Triamcinolone Acetonide | 14 | $227 | $16 |
2020: 3 drugs
| Fluocinonide | 12 | $641 | $53 |
| Ketoconazole | 16 | $330 | $21 |
| Triamcinolone Acetonide | 18 | $249 | $14 |
Money from drug and device companies
$46 in 2021
| 2021 | 1 | 1 | None | $46 |
| 2019 | 1 | 1 | None | $115 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Humira | $46 | 1 payment
|
See the published payment
| AbbVie | Meals · 2021-01-21 | Humira | $46 |
See earlier years (2019)
2019: $115
| Pfizer | Eucrisa | $115 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780115741
- Licence
- CA A156863California A156863: Current · expires 2028-07-31
- Trained
- Stanford University School of Medicine, 2017
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ND0101X (207ND0101X); Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 450 Broadway St # B, Redwood City, CA, 94063
- NPI first listed
- 2017-03-22
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Broadway St Fl B4, Redwood City, CA, 94063